QUERZOLI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 6.121
EU - Europa 2.540
AS - Asia 1.379
OC - Oceania 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 10.057
Nazione #
US - Stati Uniti d'America 6.116
IT - Italia 940
CN - Cina 763
UA - Ucraina 435
DE - Germania 362
TR - Turchia 281
SG - Singapore 262
GB - Regno Unito 221
SE - Svezia 162
PL - Polonia 153
FI - Finlandia 102
FR - Francia 48
BE - Belgio 47
ID - Indonesia 44
RU - Federazione Russa 24
CZ - Repubblica Ceca 18
IN - India 12
RO - Romania 9
IR - Iran 7
BR - Brasile 5
EU - Europa 4
HK - Hong Kong 4
LT - Lituania 4
AU - Australia 3
CA - Canada 3
NZ - Nuova Zelanda 3
VN - Vietnam 3
AT - Austria 2
CH - Svizzera 2
IE - Irlanda 2
MX - Messico 2
NL - Olanda 2
BG - Bulgaria 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
JP - Giappone 1
KE - Kenya 1
LB - Libano 1
MD - Moldavia 1
PT - Portogallo 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 10.057
Città #
Woodbridge 795
Chandler 612
Fairfield 593
Ann Arbor 548
Jacksonville 501
Houston 375
Ashburn 362
Wilmington 264
Seattle 243
Singapore 200
Izmir 197
Cambridge 193
Nanjing 160
Warsaw 152
Beijing 120
Princeton 113
New York 109
Milan 90
Ferrara 87
Boardman 78
Shanghai 78
Nanchang 71
Bremen 69
Dearborn 61
San Diego 59
Brussels 46
Shenyang 45
Jakarta 43
Hebei 41
Tianjin 39
Falls Church 36
Rome 35
Los Angeles 34
Changsha 31
Santa Clara 28
San Mateo 24
Redwood City 23
Bologna 22
Auburn Hills 21
Jiaxing 21
Jinan 21
Zhengzhou 21
Munich 19
Guangzhou 16
Norwalk 16
Mountain View 14
Addison 13
Brno 13
Philadelphia 12
Verona 12
Orange 11
Des Moines 10
Hefei 10
Kunming 10
Washington 10
Bari 9
Napoli 9
Hangzhou 8
Helsinki 8
Leawood 8
London 8
Monmouth Junction 8
Naples 8
Ningbo 8
Palermo 8
Chicago 7
Parma 7
Trento 7
Fuzhou 6
Padova 6
Taizhou 6
Tappahannock 6
Augusta 5
Catania 5
Cento 5
Ferrara di Monte Baldo 5
Florence 5
Indiana 5
Reggio Emilia 5
Siena 5
Ardabil 4
Chieti 4
Dallas 4
Foligno 4
Forlì 4
Hong Kong 4
Messina 4
New Delhi 4
Olomouc 4
Rimini 4
Torino 4
Wuhan 4
Caserta 3
Dong Ket 3
Fano 3
Frankfurt am Main 3
Haikou 3
Kaunas 3
Mumbai 3
Prato 3
Totale 7.066
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 529
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 292
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 165
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 163
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 163
Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation 146
Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases. 139
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 139
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 132
CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer 131
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 126
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 125
Breast Cancer and Simian Virus 40 Infection 125
Serologic investigation on undifferentiated nasopharyngeal carcinoma and Simian Virus 40 infection 118
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 115
Espressione dell'oncoproteina virale antigene T-grande di SV40 in carcinomi mammari infiltranti valutata su Tissue micro arrays (TMAs) 113
null 111
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 110
CD8 + ve cell infiltration correlates with angiogenesis in non-small cell lung cancer (NSCLC) of patients with chronic obstructive pulmonary disease 108
Application of quantitative analysis to biologic profile evaluation in breast cancer 108
null 107
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 106
Oncogenic role of miR-483-3p at the IGF2/483 locus 106
null 101
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 100
Sentinel node study in early breast cancer 100
miR-501 overexpression in renal carcinomas 99
Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma) 99
Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast Cancer 98
null 98
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 97
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 97
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 96
Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer 96
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 96
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 95
The 70 Gene Mammaprint signature: Ferrara's experience 95
null 94
Lymph node micrometastases do influence breast cancer outcome 94
null 94
null 93
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: Evidence from a retrospective study 92
Espressione dei MicroRNA nei carcinomi mammari 92
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer 92
Tumour-infiltrating CD8+ cells expressing IL-10, but not CD8+, CD4+ and CD68+ cells, are associated with a better prognosis in patients with NSCLC 90
Observational DEMETRA STUDY: survival of metastatic breast carcinoma patients after treatment with Trastuzumab 89
Core needle biopsy in invasive breast cancer prognostic/predictive power: concordance with surgical speciemen and impact of immunophenotypes 89
Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer 89
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 88
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer 87
Factors responsible of scintigraphic false-negative sentinel lymph node detection in brest cancer 87
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 87
null 86
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 85
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 85
The 70 gene Mammaprint signature: a comparison with traditional clinico-pathological parameters. 85
Sentinel node and bone marrow micro metastases and nanometastases 85
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 85
null 85
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 84
null 84
MicroRNAs: toward the clinic for breast cancer patients 82
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 81
Morphological parameters of flat epithelial atypia (FEA) in stereotactic vacuum-assisted needle core biopsies do not predict the presence of malignancy on subsequent surgical excision 81
Expression of IL-10 by CD8+ T Cells Is a Favorable Prognostic Factor in Non-Small Cell Lung Cancer 81
Quantitative immunoprofiles of breast cancer performed by image analysis 80
Increased of A3 adenosine receptors by depleted expression of polycystic kidney disease-1 gene (PKD1) in human renal cell and tissues: implication for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells 79
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 79
Prognostic and predictive factors related to metastatic breast cancer clinical history: an outcome study [Fattori prognostici e predittivi nella storia clinica del carcinoma metastatico della mammella: Uno studio di esito] 75
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 75
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 75
null 75
Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-insitutional study in Italy 75
Interleukin (IL)-10 expression in non-small cell lung cancer is associated with cigarette smoking 75
Biology and prognosis of 1685 recently diagnosed HER2 positive breast carcinomas 73
Increased neurokinin-2 receptor expression in alveolar macrophages of smokers with COPD 72
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 72
Prevalence of post-stress myocardial stunning by gated-SPECT in diabetic patients: results of a prospective, multi-center trial 71
Interobserver reproducibility of immunohistochemical HER-2/neu evaluation in human breast cancer: The real-world experience 69
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 69
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 69
null 66
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 66
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 66
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 65
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 64
null 64
Clinical-diagnostic meaning of mammary uptake accidentally detected during 18F-FDG PET/CT (PET): comparison between radiological imaging and histopathology. 62
A case of invasive solid papillary breast carcinoma resembling tall cell variant of papillary thyroid carcinoma 62
null 60
Pattern of distant recurrence according to the molecular subtypes identified by immunohistochemistry in women with early breast cancer 60
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 60
Tumor infiltrating lymphocyte (TIL) and CD8+ cells in TNBC: new prognostic markers 59
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 59
Role of the miR-501 in Renal Carcinomas 57
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 56
Fattori predittivi del rischio di ulteriore metastatizzazione linfonodale ascellare in pazienti con linfonodo sentinella micrometastatico da tumore della mammella in fase precoce 54
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 54
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 51
Tumor infiltrating lymphocytes in triple negative breast cancer and correlations with prognosis 49
Totale 9.607
Categoria #
all - tutte 42.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 203
Totale 42.457


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.501 0 0 0 264 124 236 183 199 151 198 101 45
2020/20211.310 138 110 71 175 45 145 46 142 27 154 179 78
2021/20221.285 50 118 70 87 95 52 66 87 52 104 101 403
2022/20231.372 98 113 55 184 263 213 63 126 142 7 67 41
2023/2024729 68 63 45 21 56 167 30 53 8 17 30 171
2024/2025403 91 84 225 3 0 0 0 0 0 0 0 0
Totale 10.199